Michael Richtmyer Appointed as Head of Operations at Integrated BioPharma’s Subsidiary
Position
Head of Operations
Company
INTEGRATED BIOPHARMA
HillsideManufacturingBiotechnologyHealth CareDietary SupplementsDescription
On August 20, 2026, Integrated BioPharma, Inc. announced the appointment of Michael Richtmyer to the position of Head of Operations at Manhattan Drug Company, Inc., a wholly owned subsidiary. This strategic move is aimed at enhancing operational efficiency and driving the company's growth.
Quick answer
Michael Richtmyer Appointed as Head of Operations at Integrated BioPharma’s Subsidiary (August 20, 2026). INTEGRATED BIOPHARMA is based in Hillside, New Jersey, United States.
- Who is the new Head of Operations at INTEGRATED BIOPHARMA?
- INTEGRATED BIOPHARMA named Michael Richtmyer Head of Operations, announced August 20, 2026.
- What did INTEGRATED BIOPHARMA announce on August 20, 2026?
- On August 20, 2026, Integrated BioPharma, Inc. announced the appointment of Michael Richtmyer to the position of Head of Operations at Manhattan Drug Company, Inc., a wholly owned subsidiary. This strategic move is aimed at enhancing operational efficiency and driving the company's growth.
- What does INTEGRATED BIOPHARMA do?
- Integrated Biopharma, Inc. is a Delaware-based biopharmaceutical company specializing in the development and manufacturing of dietary supplements and pharmaceutical products.
- Where is INTEGRATED BIOPHARMA based?
- INTEGRATED BIOPHARMA is based in Hillside, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- LSL Pharma Group (September 10, 2026), Zeon Lifesciences Ltd (October 4, 2026), Baxter International (August 19, 2026) and Atomo Diagnostics (August 19, 2026) also announced leadership changes within 45 days of INTEGRATED BIOPHARMA.
Source: Fundz verified event record.
Other recent leadership changes in Dietary Supplements and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- LSL Pharma Begins Search for New Chief Financial Officer (September 10, 2026)
- Zeon Lifesciences Appoints Sundeep Talwar as Chief Executive Officer (October 4, 2026)
- Baxter Appoints John Rogers as Chief Financial Officer (August 19, 2026)
- Atomo Diagnostics Appoints Dr Cheri Walker as Interim CEO (August 19, 2026)
- ChronoScale Holdings Appoints Jerome Wong as Chief Financial Officer (August 18, 2026)
- Orchestra Life Sciences Appoints Charles Conroy as Chief Operating Officer (August 18, 2026)
Who to call at INTEGRATED BIOPHARMA, and when
A new leader at INTEGRATED BIOPHARMA brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day INTEGRATED BIOPHARMA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at INTEGRATED BIOPHARMA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at INTEGRATED BIOPHARMA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment INTEGRATED BIOPHARMA changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
INTEGRATED BIOPHARMA changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.